Kefir drink causes a significant yet similar improvement in serum lipid profile, compared with low-fat milk, in a dairy-rich diet in overweight or obese premenopausal women: A randomized controlled trial

Journal of Clinical Lipidology

Volumn 11, Issue 1, 2017, Pages 136-146

  Fathi, Yasamin ^a   Ghodrati, Naeimeh ^b   Zibaeenezhad, Mohammad Javad ^c   Faghih, Shiva ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dairy products; Kefir; Lipoproteins; Milk; Obesity; Overweight; Premenopause; Randomized controlled trial

Indexed keywords

CALCIUM; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KEFIR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW FAT MILK; MILK FAT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ADULT; ARTICLE; BLOATING; BODY MASS; BODY WEIGHT MAINTENANCE; CALCIUM INTAKE; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; HUMAN; IRANIAN (CITIZEN); LIPID BLOOD LEVEL; LOW FAT DIET; MAJOR CLINICAL STUDY; MILK; OBESITY; OUTCOME ASSESSMENT; OUTPATIENT; PORTION SIZE; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; DIET; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; DIET; FEMALE; HUMANS; KEFIR; MIDDLE AGED; OBESITY; PREMENOPAUSE;

EID: 85008157782     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2016.10.016     Document Type: Article

References (59)

1. 1 Knight, J.A., Diseases and disorders associated with excess body weight. Ann Clin Lab Sci 41 (2011), 107–121.
2. 2 Klop, B., Elte, J.W., Cabezas, M.C., Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 5 (2013), 1218–1240.
3. 3 Kopelman, P.G., Obesity as a medical problem. Nature 404 (2000), 635–643.
4. 4 Azizi, F., Azadbakht, L., Mirmiran, P., Trends in overweight, obesity and central fat accumulation among Tehranian adults between 1998-1999 and 2001-2002: Tehran lipid and glucose study. Ann Nutr Metab 49 (2005), 3–8.
5. 5 Pagidipati, N.J., Gaziano, T.A., Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement. Circulation 127 (2013), 749–756.
6. 6 Franssen, R., Monajemi, H., Stroes, E.S., Kastelein, J.J., Obesity and dyslipidemia. Endocrinol Metab Clin North Am 37 (2008), 623–633 viii.
7. 7 Shen, Z., Munker, S., Wang, C., et al. Association between alcohol intake, overweight, and serum lipid levels and the risk analysis associated with the development of dyslipidemia. J Clin Lipidol 8 (2014), 273–278.
8. 8 Muscari, A., Puddu, G.M., Puddu, P., Lipid-lowering drugs: are adverse effects predictable and reversible?. Cardiology 97 (2002), 115–121.
9. 9 Mann, G.V., Spoerry, A., Studies of a surfactant and cholesteremia in the Maasai. Am J Clin Nutr 27 (1974), 464–469.
10. 10 Lopitz-Otsoa, F., Rementeria, A., Elguezabal, N., Garaizar, J., Kefir: a symbiotic yeasts-bacteria community with alleged healthy capabilities. Rev Iberoam Micol 23 (2006), 67–74.
11. 11 Ahmed, Z., Wang, Y., Ahmad, A., et al. Kefir and health: a contemporary perspective. Crit Rev Food Sci Nutr 53 (2013), 422–434.
12. 12 Guzel-Seydim, Z.B., Kok-Tas, T., Greene, A.K., Seydim, A.C., Review: functional properties of kefir. Crit Rev Food Sci Nutr 51 (2011), 261–268.
13. 13 Maeda, H., Zhu, X., Omura, K., Suzuki, S., Kitamura, S., Effects of an exopolysaccharide (kefiran) on lipids, blood pressure, blood glucose, and constipation. Biofactors 22 (2004), 197–200.
14. 14 Liu, J.R., Wang, S.Y., Chen, M.J., Chen, H.L., Yueh, P.Y., Lin, C.W., Hypocholesterolaemic effects of milk-kefir and soyamilk-kefir in cholesterol-fed hamsters. Br J Nutr 95 (2006), 939–946.
15. 15 Wang, Y., Xu, N., Xi, A., Ahmed, Z., Zhang, B., Bai, X., Effects of Lactobacillus plantarum MA2 isolated from Tibet kefir on lipid metabolism and intestinal microflora of rats fed on high-cholesterol diet. Appl Microbiol Biotechnol 84 (2009), 341–347.
16. 16 Angelis-Pereira, M.C., Barcelos Mde, F., Sousa, M.S., Pereira Jde, A., Effects of the kefir and banana pulp and skin flours on hypercholesterolemic rats. Acta Cir Bras 28 (2013), 481–486.
17. 17 Huang, Y., Wu, F., Wang, X., Sui, Y., Yang, L., Wang, J., Characterization of Lactobacillus plantarum Lp27 isolated from Tibetan kefir grains: a potential probiotic bacterium with cholesterol-lowering effects. J Dairy Sci 96 (2013), 2816–2825.
18. 18 Zheng, Y., Lu, Y., Wang, J., Yang, L., Pan, C., Huang, Y., Probiotic properties of Lactobacillus strains isolated from Tibetan kefir grains. PLoS One, 8, 2013, e69868.
19. 19 Liu, H., Xie, Y.H., Xiong, L.X., et al. Effect and mechanism of cholesterol-lowering by kluyveromyces from tibetan kefir. Advanced Materials Research, Vol. 343, 2012, Trans Tech Publ, 1290–1298 Available at: http://www.scientific.net/AMR.343-344.1290.
20. 20 St-Onge, M.P., Farnworth, E.R., Savard, T., Chabot, D., Mafu, A., Jones, P.J., Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: a randomized controlled trial. BMC Complement Altern Med, 2, 2002, 1.
21. 21 Ostadrahimi, A., Taghizadeh, A., Mobasseri, M., et al. Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Iran J Public Health 44 (2015), 228–237.
22. 22 World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310 (2013), 2191–2194.
23. 23 Fathi, Y., Faghih, S., Zibaeenezhad, M.J., Tabatabaei, S.H., Kefir drink leads to a similar weight loss, compared with milk, in a dairy-rich non-energy-restricted diet in overweight or obese premenopausal women: a randomized controlled trial. Eur J Nutr 55 (2016), 295–304.
24. 24 Beller, E.M., Gebski, V., Keech, A.C., Randomisation in clinical trials. Med J Aust 177 (2002), 565–567.
25. 25 United States Department of Agriculture. Choose My Plate. Available at: http://www.choosemyplate.gov. Accessed August 12, 2016.
26. 26 Buonopane, G.J., Kilara, A., Smith, J.S., McCarthy, R.D., Effect of skim milk supplementation on blood cholesterol concentration, blood pressure, and triglycerides in a free-living human population. J Am Coll Nutr 11 (1992), 56–67.
27. 27 The UK Department of Health. The general practice physical activity questionnaire (GPPAQ). 2013 Available at: https://www.gov.uk/government/publications/general-practice-physical-activity-questionnaire-gppaq Accessed January 09, 2016.
28. 28 Gallagher, M.L., Intake: The Nutrients and Their Metabolism. Mahan, L.K., Escott-Stump, S., Raymond, J., (eds.) Krause's food & the nutrition care process, 12th ed, 2012, Elsevier Health Sciences, USA, 32–143.
29. 29 Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972), 499–502.
30. 30 Millan, J., Pinto, X., Munoz, A., et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag 5 (2009), 757–765.
31. 31 Manickam, P., Rathod, A., Panaich, S., et al. Comparative prognostic utility of conventional and novel lipid parameters for cardiovascular disease risk prediction: do novel lipid parameters offer an advantage?. J Clin Lipidol 5 (2011), 82–90.
32. 32 Maki, K.C., Davidson, M.H., Dicklin, M.R., Bell, M., Witchger, M., Feinstein, S.B., Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease. J Clin Lipidol 5 (2011), 141–151.
33. 33 Shimodaira, M., Niwa, T., Nakajima, K., Kobayashi, M., Hanyu, N., Nakayama, T., Correlation between serum lipids and 1-hour postload plasma glucose levels in normoglycemic individuals. J Clin Lipidol 8 (2014), 217–222.
34. 34 Agirbasli, M., Tanrikulu, A., Acar Sevim, B., Azizy, M., Bekiroglu, N., Total cholesterol-to-high-density lipoprotein cholesterol ratio predicts high-sensitivity C-reactive protein levels in Turkish children. J Clin Lipidol 9 (2015), 195–200.
35. 35 Hansel, B., Nicolle, C., Lalanne, F., et al. Effect of low-fat, fermented milk enriched with plant sterols on serum lipid profile and oxidative stress in moderate hypercholesterolemia. Am J Clin Nutr 86 (2007), 790–796.
36. 36 Anderson, J.W., Konz, E.C., Obesity and disease management: effects of weight loss on comorbid conditions. Obes Res 9:Suppl 4 (2001), 326S–334S.
37. 37 Zomer, E., Gurusamy, K., Leach, R., et al. Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis. Obes Rev 17 (2016), 1001–1011.
38. 38 St-Onge, M.P., Farnworth, E.R., Jones, P.J., Consumption of fermented and nonfermented dairy products: effects on cholesterol concentrations and metabolism. Am J Clin Nutr 71 (2000), 674–681.
39. 39 Cenesiz, S., Yaman, H., Ozcan, A., Kart, A., Karademir, G., Effects of kefir as a probiotic on serum cholesterol, total lipid, aspartate amino transferase and alanine amino transferase activities in broiler chicks-in English. Med Weter 64 (2008), 168–170.
40. 40 Gilliland, S.E., Nelson, C.R., Maxwell, C., Assimilation of cholesterol by Lactobacillus acidophilus. Appl Environ Microbiol 49 (1985), 377–381.
41. 41 Noh, D.O., Kim, S.H., Gilliland, S.E., Incorporation of cholesterol into the cellular membrane of Lactobacillus acidophilus ATCC 43121. J Dairy Sci 80 (1997), 3107–3113.
42. 42 Sari, E.K., Bakir, B., Aydin, B.D., Sozmen, M., The effects of kefir, koumiss, yogurt and commercial probiotic formulations on PPARalpha and PPAR-beta/delta expressions in mouse kidney. Biotech Histochem 89 (2014), 287–295.
43. 43 Li, T., Chiang, J.Y., Regulation of bile acid and cholesterol metabolism by PPARs. PPAR Res, 2009, 2009, 501739.
44. 44 Otles, S., Cagindi, Oe, Kefir: a probiotic dairy-composition, nutritional and therapeutic aspects. Pakistan J Nutr 2 (2003), 54–59.
45. 45 Reid, I.R., Mason, B., Horne, A., et al. Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med 112 (2002), 343–347.
46. 46 Ditscheid, B., Keller, S., Jahreis, G., Cholesterol metabolism is affected by calcium phosphate supplementation in humans. J Nutr 135 (2005), 1678–1682.
47. 47 Shahkhalili, Y., Murset, C., Meirim, I., et al. Calcium supplementation of chocolate: effect on cocoa butter digestibility and blood lipids in humans. Am J Clin Nutr 73 (2001), 246–252.
48. 48 Lorenzen, J.K., Astrup, A., Dairy calcium intake modifies responsiveness of fat metabolism and blood lipids to a high-fat diet. Br J Nutr 105 (2011), 1823–1831.
49. 49 Denke, M.A., Fox, M.M., Schulte, M.C., Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr 123 (1993), 1047–1053.
50. 50 Soerensen, K.V., Thorning, T.K., Astrup, A., Kristensen, M., Lorenzen, J.K., Effect of dairy calcium from cheese and milk on fecal fat excretion, blood lipids, and appetite in young men. Am J Clin Nutr 99 (2014), 984–991.
51. 51 Fakhrawi, D.H., Cordero-MacIntyre, Z., Beesan, L., et al. Effects of dairy calcium on lipid profile in overweight/obese postmenopausal women. FASEB J, 20, 2006, A1024.
52. 52 Steinmetz, K.A., Childs, M.T., Stimson, C., et al. Effect of consumption of whole milk and skim milk on blood lipid profiles in healthy men. Am J Clin Nutr 59 (1994), 612–618.
53. 53 Ohlsson, L., Dairy products and plasma cholesterol levels. Food Nutr Res, 54, 2010, 10.3402/fnr.v54i0.5124.
54. 54 Maki, K.C., Rains, T.M., Schild, A.L., et al. Effects of low-fat dairy intake on blood pressure, endothelial function, and lipoprotein lipids in subjects with prehypertension or stage 1 hypertension. Vasc Health Risk Manag 9 (2013), 369–379.
55. 55 Drouin-Chartier, J.P., Gagnon, J., Labonte, M.E., et al. Impact of milk consumption on cardiometabolic risk in postmenopausal women with abdominal obesity. Nutr J, 14, 2015, 12.
56. 56 Maki, K.C., Nieman, K.M., Schild, A.L., et al. Sugar-sweetened product consumption alters glucose homeostasis compared with dairy product consumption in men and women at risk of type 2 diabetes mellitus. J Nutr 145 (2015), 459–466.
57. 57 Christensen, R., Lorenzen, J.K., Svith, C.R., et al. Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev 10 (2009), 475–486.
58. 58 Vaskonen, T., Dietary minerals and modification of cardiovascular risk factors. J Nutr Biochem 14 (2003), 492–506.
59. 59 Livingstone, M.B., Assessment of food intakes: are we measuring what people eat?. Br J Biomed Sci 52 (1995), 58–67.